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ABSTRACT
TRIM-NHL proteins are conserved regulators of
development and differentiation but their molecular
function has remained largely elusive. Here, we
report an as yet unrecognized activity for the mam-
malian TRIM-NHL protein TRIM71 as a repressor
of mRNAs. We show that TRIM71 is associated
with mRNAs and that it promotes translational
repression and mRNA decay. We have identified
Rbl1 and Rbl2, two transcription factors whose
down-regulation is important for stem cell
function, as TRIM71 targets in mouse embryonic
stem cells. Furthermore, one of the defining
features of TRIM-NHL proteins, the NHL domain, is
necessary and sufficient to target TRIM71 to RNA,
while the RING domain that confers ubiquitin ligase
activity is dispensable for repression. Our results
reveal strong similarities between TRIM71 and
Drosophila BRAT, the best-studied TRIM-NHL
protein and a well-documented translational repres-
sor, suggesting that BRAT and TRIM71 are part of a
family of mRNA repressors regulating proliferation
and differentiation.
INTRODUCTION
The family of TRIM-NHL ubiquitin ligases is
characterized by an N-terminal tripartite motif [TRIM;
consisting of a RING domain, B-box and coiled-coil
(CC) regions] and a C-terminal NHL domain (1). TRIM
is also found associated with other C-terminal domains
and deﬁnes a superfamily of TRIM proteins (2), many
of which are functional ubiquitin ligases. TRIM-NHL
proteins are conserved among metazoa and are key regu-
lators of development and differentiation. Mammals
express four such proteins: TRIM2, TRIM3, TRIM32
and TRIM71. However, apart from Drosophila BRAT,
which acts as a translational repressor (3–5), the molecular
functions of TRIM-NHL proteins are not well-deﬁned.
Several TRIM-NHL proteins have been identiﬁed
recently as modulators of microRNA (miRNA)-
mediated repression in mammals, ﬂies and worms (6–9).
miRNAs, in association with Argonautes (AGO) and
other proteins of miRNA-protein particles (miRNPs),
repress translation of mRNAs and accelerate their decay
by base-pairing with mRNA 30-untranslated regions (30-
UTRs). Interaction of several TRIM-NHL proteins with
AGOs and other miRNP components has been
demonstrated but the functional consequences vary:
while mammalian TRIM32 and Caenorhabditis elegans
NHL-2 are enhancers of miRNA-mediated repression
(6,9), mammalian TRIM71 and Drosophila Mei-P26 act
as negative pathway regulators (7,8).
TRIM-NHL proteins themselves are targets of miRNA
repression and C. elegans LIN-41 was the ﬁrst known
target of let-7 miRNA (10). In C. elegans, LIN-41 and
let-7 both regulate developmental timing events, LIN-41
preventing premature differentiation of epidermal skin
cells and let-7 promoting their differentiation (10). The
regulatory relationship of let-7 with LIN-41 orthologs,
TRIM71 in vertebrates and Dappled in ﬂies, is conserved
(11–15). However, while the molecular function of let-7
as a key regulator driving differentiation in development
and disease is well-deﬁned (16), little is known about the
function of LIN-41/TRIM71.
TRIM71 is highly expressed in undifferentiated cells,
such as embryonic stem (ES) cells, but becomes rapidly
down-regulated upon differentiation, when let-7 levels
rise (8). Like other proteins that sustain stemness and pluri-
potency (e.g. MYC, LIN-28 or SALL4), expression of
TRIM71 is not only negatively regulated by let-7 but also
indirectly up-regulated by ES-cell-speciﬁc miRNAs (17).
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This suggests a role for TRIM71 in themaintenance of stem
cell identity or inhibition of premature differentiation.
Although gene targeting in mice revealed that TRIM71 is
essential for embryonic viability (18), its molecular
function remains unknown.
Here we report that the association of mammalian
TRIM71 with mRNAs results in translational repression
and mRNA degradation. The NHL domain and the
central part of the protein mediate RNA interaction and
translational repression, respectively. We have identiﬁed
targets in human HEK293 and mouse ES (mES) cells
that indicate a role for TRIM71 in ES cell maintenance.
TRIM71 shares many targets with miRNAs and full
repression of these targets requires expression of both
TRIM71 and miRNAs.
MATERIALS AND METHODS
Cell culture, transfection, RNA interference and
generation of stable cell lines
Human HEK293 and HEK293 Flp-In (Invitrogen) cells
were grown in DMEM (Gibco-BRL) supplemented with
2mM L-glutamine and 10% heat inactivated FCS. mES
cells (E14TG2a.4) were cultured as described previously
(19). For time course experiments cells were treated with
5 mg/ml Actinomycin D (Sigma), 10 mg/ml Cycloheximide
(Sigma) or 10 mM MG132 (Calbiochem). Transfections
were performed using nanofectin (PAA Laboratories),
nanofectin siRNA (PAA Laboratories) or attractene
(Qiagen) transfection reagents according to manufac-
turer’s instructions. siRNAs were ordered from
Microsynth and sequences are listed in Supplementary
Table S3. To generate HEK293 Flp-In stable cell lines,
parental cells were transfected with 5.4mg pOG44, 0.6mg
of the respective pCDN5/FRT plasmid and 19.2ml
nanofectin per 10 cm dish. Cells were split 48 h post-
transfection and selection started 72–96 h post-
transfection. Selection of HEK293 Flp-In stable cell lines
was carried out using 100 mg/ml hygromycin B
(Invitrogen) and for the maintenance of HEK293 Flp-In
stable cell lines 50 mg/ml hygromycin B was added to the
culture medium. Knock-down of Trim71 in mES cells was
performed in 6-well plates using a mixture of 3 different
siRNAs speciﬁc to Trim71 or allstar negative control
siRNA (Qiagen) (at 25 nM ﬁnal) and 4 ml dharmafect1
(Dharmacon) according to manufacturer’s instructions.
Medium was changed 4 h and 24 h post-transfection and
cells were harvested 72 h post-transfection.
Plasmids
Tethering reporter plasmid pRL-5BoxB and the control
plasmid pGL-FL, as well as plasmids encoding NHA- or
HA-AGO2 and NHA-LacZ have been described (20,21).
Constructs expressing NHA-or HA-TRIM-NHL proteins
or mutants thereof were generated by PCR ampliﬁcation
of respective ORFs or fragments thereof and subsequent
cloning into pCIneo vectors that contain NHA or
HA-tags (20) using SalI and NotI sites, except for
full-length TRIM71 which is described below. For the
generation of NHA- or HA-TRIM71-NHL32 and
TRIM32-NHL71 respective fragments were PCR
ampliﬁed using PCR primer that introduced SalI/XbaI
and XbaI/NotI sites. Reporter plasmids pMIR-HMGA2,
containing the 30UTR of HMGA2 with either wt or
mutated (mut) let-7 sites, and pMIR-KRAS, containing
the 30UTR of KRAS, have been described (22). All other
30UTR reporters were generated from these vectors by
exchange of the respective 30UTRs using SacI/NaeI
sites. Respective 30UTRs were PCR ampliﬁed from
cDNA of HEK293 or mES cells using primers listed in
Supplementary Table S3.
pEGFPC1-TRIM71 was generated by releasing the
EcoRI-EcoRI and EcoRI-KpnI fragments from Image
clone AA 169781 (geneservice), and cloning into the
pEGFPC1 vector (Clontech). pCDNA5/FRT-FHA-
TRIM71 was generated in three steps: ﬁrst, a HindIII/
KpnI fragment from pEGFPC1-TRIM71 was cloned
into pCDNA5/FRT (Invitogen); second, annealed oligo-
nucleotides coding for the FLAG-HA-tag and containing
a 30 end proximal SalI site was inserted via the HindIII site
thereby destroying the 50 HindIII site but leaving the
30 HindIII site intact; third, the HindIII-HindIII
fragment remaining from the HindIII/KpnI cleavage of
pEGFPC1-TRIM71 was inserted. All other full-length
TRIM71 constructs were generated by releasing
TRIM71 from this construct using SalI/NotI sites.
pIRESneoFHA-AGO2 and pIRESneoFHA-TRIM32
have been described (23). To obtain pGFPC1- and
pHIS-MYC-TRIM32, the ORF of TRIM32 was PCR
ampliﬁed and cloned into the respective vectors via
EcoRI/BamHI or SalI/NotI sites, respectively. To con-
struct pCDNA5/FRT-FHA-TRIM32, the ORF of
TRIM32 including FLAG-HA-tag were released from
pIRESneo-FHA-TRIM32 and inserted into the
pCDNA5/FRT vector using KpnI/BamHI sites. For
generation of pCDNA5/FRT-FHA-TRIM71 deletion
mutants TRIM32 was released from pCDNA5/
FRT-FHA-TRIM32 using SalI/NotI sites, leaving the
FLAG-HA-tag, and fragments of TRIM71 were PCR
ampliﬁed and inserted into the vector. Point mutations
were introduced by site-directed mutagenesis (24). In
case of TRIM71, point mutations were ﬁrst introduced
in TRIM71-NHLonly constructs; SmaI/NotI fragments
were then released and introduced into full-length
TRIM71. All constructs were veriﬁed by sequencing.
Luciferase assays
Transfections were performed in 12 - or 24-well formats
and done in triplicate. For tethering reporter experiments
transfection mixtures contained 500 ng pGL-FL, 10 ng
RL-5BoxB, 20 ng NHA- or HA-fusion-protein expressing
plasmids and 1.6ml nanofectin per 3 wells of a 12-well
plate. For 30UTR reporter experiments transfection
mixtures contained 500 ng pMIR-30UTR-reporter con-
structs, 20 ng protein expressing plasmids and 1.6 ml
nanofectin per 3 wells of a 12-well plate. Transfection
mixtures for reporter gene experiments with simultaneous
knock-down of AGO or Pumilio (PUM) proteins con-
tained 2 mg pMIR-30UTR reporter, 50 ng protein coding
plasmids, siRNAs directed against AGO1, AGO2, PUM1
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or PUM2 or allstar negative control siRNA (at 100 nM
ﬁnal) and 8 ml nanofectin siRNA reagent per 3 wells of a
12-well plate. Transfection mixtures for miR-302
co-transfection experiments contained 1.2 mg pMIR-
E2F7 reporter, 20 ng protein expressing plasmids,
miR-302 b mimic (Dharmacon) or allstar negative
control siRNA (at 10 nM ﬁnal) and 4.5ml attractene per
3 wells of a 24-well plate. Transfections of reporter gene
assays in mES cells were done with attractene.
Transfection mixtures contained 2 mg pGL-FL, 400 ng
RL-5BoxB, 200 ng NHA- or HA-expressing plasmids
and 9 ml of attractene per 3 wells of a 12-well plate or
1.2mg pMIR 30UTR-reporter, siRNAs directed against
Trim71 or allstar negative control siRNA (100 nM ﬁnal)
and 4.5 ml attractene per 3 wells of a 24-well plate. Cells
were lysed 48 h or, in case of knock-down experiments,
72 h post-transfection using passive lysis buffer
(Promega) and ﬁreﬂy (FL) and renilla luciferase (RL)
activities were measured with the Dual-Luciferase
Reporter Assay System (Promega). For all luciferase
assays, values represent means of two to ﬁve independent
experiments, each performed in triplicate, and error bars
show standard error of the mean (s.e.m.).
Immunoprecipitation and western blotting
Transient-transfected HEK293 cells or HEK293 Flp-In
cells constitutively expressing FLAG-HA-tagged proteins
were washed twice with ice-cold PBS, lysed in whole cell
extraction buffer (WCE) [50mM Tris-HCl, pH 7.4,
150mM NaCl, 0.5% NP-40, 10% Glycerol, 0.2mM
EDTA, 2mM EGTA, 50mM NaF, 10mM
Glycerophosphat, 1mM NaVanadate, 2mM DTT and
Complete protease inhibitor mix (Roche)] for 30min on
ice and cleared by centrifugation at 13 000g for 15min at
4C. The cleared lysate was incubated with FLAG M2
beads (Roche) for 2 h at 4C on a rotating wheel. When
indicated, 250 mg/ml RNase A (Roche) was added to the
reaction. Beads were washed 5 with WCE or, if samples
were used for ms analyses, 2 with WCE and 3 with
TBS (20mM Tris-HCl, pH 7.4, 150mM NaCl). Bound
proteins were eluted with 150 ng/ml FLAG peptide
(Roche) in either TBS or WCE for 30min at 4C.
For western blot analyses, lysates or immunoprecipitates
(IPs) were boiled in Laemmli buffer, separated by
SDS-PAGE and electro-transferred to PDVF membranes.
The following primary antibodies were used: anti-FLAG
M2, 1:5000 (Sigma); anti-GFP, 1:5000 (Roche, 1814460);
anti-HA (9F10), 1:2000 (Roche); anti-AGO2 (M01),
1:1000 (Abnova); anti-AGO2 (11A9), 1:1000 (Ascenion);
anti-DDX3X, 1:500 (Milipore, 09-80); anti-HSP-90
(D19), 1:2000 (Santa Cruz, sc-1057); anti-HSP-70, 1:5000
(Santa Cruz, sc-32239); anti-MOV10, 1:1000 (Novus,
NB100-77314); anti-MYC (9E10), 1:200 (Santa Cruz,
sc-40); anti-PABP1, 1:5000 (Cell Signaling Technology);
anti-PUM1, 1:5000 (Bethyl, A300-201A); anti-PUM2,
1:2000 (Bethyl, A300-202A); anti-a-tubulin, 1:10 000
(Sigma T5168); anti-TRIM71, 1:500 (kind gift of
G. Wulczyn) (8); anti-Ubiquitin (P4D1), 1:1000 (Santa
Cruz, sc-8014), anti-XRN1, 1:5000 (Bethyl, A300-443A)
and anti-XRN2, 1:5000 (Bethyl, A301-102A).
RNA-immunoprecipitation
RNA-immunoprecipitation (RIP) methodology was
adapted from previously described reports (25,26).
Brieﬂy, HEK293 Flp-In cells stably expressing FLAG-
HA-tagged proteins or the parental cells were washed
twice with ice-cold PBS, scraped of the plates in PBS and
pelleted by centrifugation at 3000g for 5min at 4C. Cells
were lysed in lysis buffer (10mM HEPES pH 7, 100mM
KCl, 2mM EDTA, 0.5% NP-40, 2mM DTT, 50U/ml
RNaseOUT (Invitrogen) and Complete protease inhibitor
cocktail) for 15min on ice and the lysate was cleared by
centrifugation at 13 000g for 15min at 4C. Protein concen-
tration was determined using Bradford reagent. Lysates
were incubated with FLAG M2 beads for 2 h at 4C on a
rotating wheel. Beads were washed 5 with NT2-RIP
buffer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 5mM
MgCl, 0.05% NP-40 and 2mM DTT) and bound
proteins were eluted with 150 ng/ml FLAG peptide in
NT2-RIP buffer containing 50U/ml RNaseOUT and
complete protease inhibitor cocktail for 30min at 4C.
RNA was extracted using Trizol (Invitrogen) and used
for RT-qPCR or microarray analysis. In later case RNA
was further treated with RNase-free DNaseI and cleaned
up using RNeasy columns (Qiagen).
Results
TRIM71 is associated with mRNPs
To investigate TRIM71 function, we constructed HEK293
cell lines stably expressing FLAG-HA-tagged-TRIM71.
Immunoﬂuorescence analyses of these cells revealed
granular and perinuclear cytoplasmic staining of
TRIM71 and its partial co-localization with AGO2 and
DDX6 (also known as RCK/p54) (Supplementary
Figure S1), resembling its previously reported localization
(8). To identify TRIM71-associated proteins, we immuno-
puriﬁed FLAG-HA-tagged-TRIM71 and characterized
co-puriﬁed proteins by mass spectrometry (MS). TRIM71
associated with many proteins involved in aspects of
mRNA function (Supplementary Table S1). The associ-
ation of some proteins was conﬁrmed by western
blotting (Figure 1). In addition to proteins identiﬁed by
MS, PUM1 and PUM2 were included in the analysis as
their Drosophila homolog PUM is an interacting partner
of Drosophila BRAT (5). All analysed proteins, except
HSP70 and HSP90, associated with TRIM71 in an
RNA-dependent fashion; their association decreased
upon treatment with RNase A.
TRIM71 is a repressor of mRNA function
The RNA-dependent association of TRIM71 with many
mRNA-binding proteins and the established function
of BRAT as a translational repressor prompted us to
examine possible TRIM71 activity in regulating protein
synthesis. We fused HA-TRIM71 to the  phage
N-peptide (resulting in the protein NHA-TRIM71),
which speciﬁcally recognizes boxB hairpins and thus can
target the fusion-protein to a RL reporter mRNA contain-
ing boxB sites in its 30UTR (RL-5boxB) (Figure 2a).
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As shown in Figure 2b, expression of NHA-TRIM71 re-
pressed RL activity, but not HA-TRIM71 or NHA-LacZ
control proteins when expressed at similar levels. The re-
pression was comparable to that of NHA-AGO2.
Measurements of mRNA levels by RT-qPCR showed
that the decrease in RL level was accompanied by a
partial decrease in RL-5boxB mRNA (Figure 2c). Thus,
inhibition of protein synthesis by tethered TRIM71 may
results from translational repression and mRNA
degradation.
Identiﬁcation of TRIM71 targets in HEK293 cells
As TRIM71-mediated repression of protein synthesis was
accompanied by a decrease in mRNA level, we sought to
identify potential TRIM71 targets using mRNA arrays.
HEK293 cells do not express endogenous TRIM71;
hence we compared the mRNA proﬁle of HEK293 cells
stably expressing FLAG-HA-TRIM71 to that of parental
cells. TRIM71 expression led to down-regulation of 524
and up-regulation of 297 transcripts by at least 1.5-fold
(P< 0.01) (Supplementary Table S2).
To identify mRNAs down-regulated due to direct tar-
geting by TRIM71, as opposed to mRNAs misregulated
due to secondary effects, we performed RIP, expecting
direct TRIM71 targets to associate with the protein.
Speciﬁcally, we immunopuriﬁed FLAG-HA-TRIM71
from HEK293 cells stably expressing the protein,
isolated bound RNA, and quantiﬁed transcripts selected
from the list of mRNAs down-regulated by TRIM71
(Supplementary Table S2) by RT-qPCR (for western
analysis of protein input and IPs, see Supplementary
Figure S2a). Of the 21 transcripts analysed, 18 were
down-regulated in cells expressing TRIM71, compared
with parental HEK293 cells (Figure 2d, top), conﬁrming
the array results. Moreover, nine transcripts showed en-
richment in the FLAG-HA-TRIM71 precipitate
compared with control IP (Figure 2d, bottom). These
transcripts likely represent bonaﬁde TRIM71 targets as
they were associated with TRIM71 and their mRNA
levels decreased upon TRIM71 expression.
To determine if the observed decrease in mRNA levels
mediated by TRIM71 is a result of accelerated mRNA
degradation, we compared decay rates of several identiﬁed
TRIM71 target mRNAs in control HEK293 cell line and
the cell line stably expressing TRIM71. Transcription was
stopped with actinomycin D and cytoplasmic mRNA
levels were measured at different time points up to 3 h
after addition of the drug. As shown in Figure 2e, decay
rates of endogenous CCNE2, STAT5B, E2F7 or MYB
were markedly accelerated in the presence of TRIM71,
while the decay of MYC, which was not identiﬁed as a
TRIM71 target, was unaffected.
Many mRNA regulatory proteins bind to and regulate
mRNA targets via their 30UTR. To test whether this
applies to TRIM71-mediated regulation, we constructed
FL reporters containing 30UTRs of the identiﬁed bonaﬁde
TRIM71 targets. The FL-30UTR reporter plasmids (also
expressing an RL control reporter) were co-transfected
with plasmids encoding either TRIM71 or LacZ. The
30UTR of KRAS, which was not identiﬁed as a TRIM71
target in the array analyses, served as an additional
control. Expression of TRIM71 led to a more than
3-fold repression of the CCNE2 30UTR reporter and to
a 1.6 - to 2-fold repression of HOXA5, STAT5B, ZNF362
and E2F7 reporters (Figure 2f), indicating that TRIM71
acts via the 30UTR of these target mRNAs. Repression of
reporters bearing 30UTRs of MYB, CDH1 and HOXA6
was less pronounced. Measurement of the RNA level of
the CCNE2 30UTR reporter revealed that the decrease in
the reporter FL activity induced by TRIM71 was
accompanied by a partial decrease in the reporter
mRNA level (Figure 2g), while the level of the KRAS
30UTR control reporter was unaffected. Hence, the
effect of TRIM71 on the function of 30UTR reporters
appears to result from a combination of translational re-
pression and mRNA degradation, similarly as in the case
of 5boxB reporters (Figure 2c).
Collectively, these data indicate that TRIM71 associates
with 30UTRs of many mRNAs and that this association
represses protein synthesis, accompanied by the decrease
in mRNA abundance due to accelerated mRNA decay.
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Figure 2. TRIM71 is a repressor of mRNA function. (a) Schematic representation of the RL-5boxB reporter used in this study. The RL-5boxB
reporter contains RL coding sequence and a 30UTR with ﬁve boxB sites. (b) (top) Repression of RL-5boxB by NHA-AGO2 or NHA-TRIM71.
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(e) TRIM71 accelerates mRNA decay. HEK293 cells stably expressing FLAG-HA-TRIM71 (TRIM71) or parental control cells (Parental) were
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(continued)
Identiﬁcation of TRIM71 targets in mES cells
TRIM71 is highly expressed in stem cells, including ES cells
(8,12,18). To examine whether TRIM71 acts as a repressor
of mRNAs in a more physiological context, we ﬁrst tested
the effect of tethering TRIM71 to the RL-5boxB reporter
in mES cells. Tethering of TRIM71 led to repression of the
reporter similar to that found in HEK293 cells (Figure 3a),
indicating that the protein also represses mRNA function
in mES cells. The effect of TRIM71 on RL-5boxB mRNA
levels was however less pronounced in mES cells than in
HEK293 cells (Figure 3b).
Figure 2. Continued
treated with 5 mg/ml Actinomycin D (ActD) to stop transcription. Levels of indicated endogenous mRNAs were analysed at indicated time points
after addition of ActD by RT-qPCR. RT-qPCR values were normalized to GAPDH and values obtained in the absence of ActD were set to 1.
(f) Repression of indicated FL-30UTR reporter constructs by TRIM71. HEK293 cells were co-transfected with plasmids expressing the indicated FL
reporters together with RL control and plasmids expressing either TRIM71 or LacZ as control. FL was normalized to RL and values of normalized
FL produced in the presence of LacZ were set to 1. (g) Determination of the effect of TRIM71 on RNA level of the FL-30UTR reporters by
RT-qPCR. HEK293 cells were co-transfected with plasmids expressing the indicated FL reporters together with RL control and plasmids expressing
either TRIM71 or LacZ as control. Panels (b), (c), (f) and (g) *P-value< 0.05; **P-value< 0.01.
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TRIM71 in mES cells. mES cells were transfected with a combination of three siRNAs against Trim71 (TRIM71 KD) or a non-targeting control
siRNA (ctrl). 72 h post-transfection cells were lysed and western blots were probed with indicated antibodies. (d) Luciferase reporter assay with FL
reporters containing 30UTRs of candidate TRIM71 targets. Luciferase reporter assays were performed in HEK293 cells as described in Figure 2f.
(e) De-repression of TRIM71 target reporters upon TRIM71 knock-down in mES cells. mES cells were co-transfected with indicated FL-30UTR
reporters and siRNAs against Trim71 (TRIM71 KD) or non-targeting control siRNA (ctrl). FL was normalized to RL and values of normalized FL
from cells treated with the ctrl siRNA were set to 1. *P-value< 0.05; **P-value< 0.01.
Nucleic Acids Research, 2013, Vol. 41, No. 1 523
To identify TRIM71 targets in mES cells, we knocked-
down TRIM71 using a combination of three different
siRNAs. The siRNAs strongly decreased TRIM71 protein
level (Figure 3c). The effect of TRIM71 knock-down on
global mRNA levels was relatively mild, consistent with
the mild effect of TRIM71 on RL-5boxB mRNA levels
observed in the tethering reporter assay (Figure 3b), poten-
tially indicating an involvement of cell-type-speciﬁc factors
in mediating the TRIM71 response. We detected an
up-regulation of 77 and down-regulation of 41 genes by at
least 1.5-fold (P< 0.05) (Supplementary Table S2). Of the
TRIM71 target genes identiﬁed in HEK293 cells, only
CCNE2 and E2F7 were slightly up-regulated upon
TRIM71 knock-down in mES cells.
To identify TRIM71 targets relevant for the proposed
function of TRIM71 in ES cell maintenance, we con-
structed FL reporters bearing 30UTRs of several candidate
target mRNAs. Candidate mRNAs were selected on the
following criteria: up-regulation upon TRIM71
knock-down, up-regulation upon ES cell differentiation
when TRIM71 levels decline (J. Krol and W.F. unpub-
lished results), or previous implication in maintenance or
repression of stem cell identity. Expression of TRIM71 in
HEK293 cells led to strong repression of the Rbl1, Rbl2
and Ccne2 reporters and intermediate repression of the
Ccnd2 reporter (Figure 3d). Importantly, the Rbl1, Rbl2,
Ccnd2 and Ccne2 reporters also showed signiﬁcant
up-regulation upon knock-down of TRIM71 in mES
cells (Figure 3e), indicating their repression by endogen-
ous TRIM71.
The TRIM71 RING domain is dispensable for repression
Having established that TRIM71 represses mRNA
function in both HEK293 and mES cells, we asked
which domains of the protein mediate this effect. To fa-
cilitate the analysis, HEK293 cells were used as they lack
endogenous TRIM71. In TRIM71, the TRIM motif
consists of a RING, two B-boxes and a CC region,
followed by ﬁlamin (Fil) homology and NHL domains
(Figure 4a). We tested mutants lacking the RING
domain and B-box1 (RING/B1), the entire TRIM
motif (thus lacking the RING domain, the two B-boxes
and the CC region; TRIM), or the NHL domain
(NHL) in tethering and 30UTR-reporter assays.
Deletion of TRIM strongly attenuated repression
whereas deletion of either RING/B1 or NHL had no
effect when mutants were tethered to the mRNA
(Figure 4b). Thus, RING/B1 and NHL domains do not
contribute to repression. The RING/B1 mutant re-
pressed 30UTR reporters of CCNE2, HOXA5, STAT5B
or E2F7 genes as efﬁciently as the full-length protein
but, in marked contrast, mutants lacking either TRIM
or NHL failed to repress the 30UTR reporters (Figure 4c).
These results indicate that the RING/B1 domain, and
thus ubiquitin ligase activity (8), is dispensable for
TRIM71-mediated repression. While the TRIM domain
was essential in both assays, the NHL domain was
required for repression of the 30UTR reporters but not
when the protein was tethered to mRNA, suggesting
that the NHL domain targets TRIM71 to RNA.
The NHL domain is needed to target TRIM71 to RNA
To test the hypothesis that NHL targets TRIM71 to
RNA, we generated cell lines stably expressing
FLAG-HA-TRIM and -NHL mutants and performed
RIP (Figure 4d and Supplementary Figure S2b). In
RT-qPCR analyses on input material (Figure 4d, top)
both mutants failed to destabilize TRIM71 targets, con-
ﬁrming the results of activity assays obtained with 30UTR
reporters (Figure 4c). However, analysis of RNA samples
immuno-selected by TRIM and NHL proteins
revealed different reasons for their failure to repress
targets. The TRIM mutant associated with RNA
whereas the NHL mutant did not (Figure 4d, bottom).
Next, we examined the ability of deletion mutants to
pull down identiﬁed TRIM71-associated proteins
(Figure 1). Deletion of RING/B1 or the entire TRIM
domain did not affect association with any protein
tested (Figure 4e). However, deletion of NHL abolished
association with all proteins whose interaction was sensi-
tive to RNase A (Figure 1). Moreover, these proteins were
pulled down by the isolated NHL domain (NHLonly)
(Supplementary Figure S3a). This is consistent with the
notion that NHL is necessary and sufﬁcient for associ-
ation of TRIM71 with RNA and that it mediates the
RNA-dependent association of TRIM71 with other
mRNA-binding proteins.
In conclusion, our data demonstrate that the NHL
domain is necessary and sufﬁcient to target TRIM71 to
RNA.
A sub-region of TRIM mediates repression together with
the Fil domain
Having shown that deletion of the entire TRIM region but
not of either RING/B-box1 or NHL abolishes
TRIM71-mediated repression in the tethering assay, we
identiﬁed the minimal region needed for repression
(Supplementary Figure S4b). Surprisingly, the tethered
TRIM domain (TRIMonly) repressed protein synthesis
only weakly. The TRIMonly mutant differs from the
fully repressive NHL mutant by the absence of the Fil
domain. Therefore, we tested a further mutant encompass-
ing part of B-box2, the CC and Fil region (B2*-CC-Fil)
(Supplementary Figure S4b). This mutant induced consid-
erable repression and we concluded that the minimal
domain needed to execute repression consists of the CC
and Fil domains.
Single-point mutations within the NHL domain abolish
TRIM71-mediated repression
Association of Drosophila BRAT with RNA occurs via its
NHL domain, mediated by the RNA-binding protein
(RBP) PUM (5). The crystal structure of the BRAT
NHL domain revealed a six-bladed ß-propeller with
each blade consisting of one NHL repeat (27). The
domain has an electropositive ‘top’ and an electronegative
‘bottom’ surface. Residues at the top are crucial for the
interaction with PUM and their mutation can result in
the brat mutant phenotype (27,28), underscoring their im-
portance. Alignment of BRAT and TRIM71 showed
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Figure 4. The NHL domain targets TRIM71 to RNA. (a) Schematic representation of human TRIM71 and its deletion mutants. The RING domain
(R) is shown in red, the two B-boxes (B1 and B2) in orange, the CC domain in yellow, the Fil domain in blue and the NHL domain, composed of
6 NHL repeats, in green. The RING domain, the B-boxes and the CC domain constitute the TRIM motif. Note that RING/B1 mutant has also a
part of B-box2 deleted. (b) (top) Repression of RL-5boxB by NHA-TRIM71 and deletion mutants thereof in HEK293 cells. Experiments were
performed as described in Figure 2b. (bottom) Expression of TRIM71 and its deletion mutants was estimated by western blotting with antibodies
against HA. (c) Repression of the indicated FL-30UTR reporters by TRIM71 and deletion mutants thereof in HEK293 cells. The experiments were
performed as described in Figure 2f. (d) RIP experiment. Levels of indicated endogenous mRNAs in HEK293 cells stably expressing FLAG-HA-
TRIM71 (TRIM71), FLAG-HA-TRIM (TRIM), FLAG-HA-NHL (NHL) were compared to those of the parental control cell line not
expressing any FLAG-HA-tagged protein (parental) before (Input) and after immunoprecipitation with FLAG-M2 afﬁnity gel (IP). RT-qPCR values
were normalized for GAPDH mRNA. Values obtained from parental cells were set to 1. Western blots showing protein expression and IP efﬁciency
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conservation of residues important for the BRAT and
PUM interaction (Supplementary Figure S5a).
Individual mutation of each of the four conserved
residues completely abrogated repression of 30UTR
reporters by TRIM71, demonstrating the importance of
its NHL domain and functional similarities between
TRIM71 and BRAT (Figure 5a). However, when the
point mutants were tested in the tethering assay, where
RNA binding is dispensable, two mutants showed repres-
sion similar to that of wild-type (wt) TRIM71 but, surpris-
ingly, repression was partially relieved for the other two
(Figure 5b). The observation that deletion of the entire
NHL domain does not affect repression while two
single-point mutations (GD and HL) within it partially
abrogate repression suggests that mutation of the NHL
domain may cause a conformational change that affects
intra- or intermolecular interactions of the protein.
All single-point mutants were expressed at levels similar
to that of the wt protein (Figure 5b, bottom). However,
the two mutants showing only partial repression in the
tethering assay also displayed a stronger interaction with
HSP70 and HSP90 (Supplementary Figure S5b), possibly
indicative of misfolding. Notably, one point mutant
(YA) but not others, still pulled down most of the
RNA-dependent interacting partners, suggesting that the
properties of the four point mutants are not identical
although they are all affected in the ability to repress
target genes.
We conclude that NHL domain residues implicated in
the association between BRAT and PUM and conserved
between TRIM71 and BRAT are also important for
TRIM71 mediation of repression.
Knock-down of PUM proteins does not affect TRIM71-
mediated repression
Similarity of effects of the NHL domain point mutations
on activity of TRIM71 and BRAT, and the detected
NHL-dependent association of TRIM71 with PUM1 and
PUM2 (Figure 4e), prompted us to investigate whether
PUM proteins are involved in targeting TRIM71 to
RNA. Mammals express two close homologs of
Drosophila PUM, PUM1 and PUM2, which both bind
to an 8-nt consensus motif UGUA(A/U/C)AUA and
share an overlapping set of mRNA targets (26,29).
We ﬁrst analysed the occurrence of the PUM consensus
motif in transcripts affected by TRIM71 expression
[either overexpression in HEK293 cells (Supplementary
Table S2) (Figure 6a) or knock-down in mES cells
(Supplementary Table S2) (data not shown)]. The motif
was not found to be enriched among predicted TRIM71
targets (Figure 6a).
Although the bioinformatic analysis argues against
TRIM71 being recruited to RNA via the PUM motif, it
does not exclude involvement of PUM1/2 in targeting
TRIM71 to RNA, possibly to sites other than the
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Figure 5. Individual mutations of conserved residues within the NHL domain abrogate TRIM71 function. (a) Repression of indicated FL-30UTR
reporter constructs by TRIM71 and indicated TRIM71 point mutants in HEK293 cells. HEK293 cells were co-transfected with plasmids expressing
the indicated FL-30UTR reporter constructs together with RL control and plasmids expressing either TRIM71, indicated TRIM71 point mutants or
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Figure 4. Continued
are shown in Supplementary Figure S2b. Note that, in contrast to other mRNAs, the HOXA5 mRNA level was decreased in cells expressing
FLAG-HA-TRIM, for reasons not yet identiﬁed. (e) Immunoprecipitations with anti-FLAG M2 afﬁnity gel (FLAG-IP) from HEK293 cells
transiently transfected with FLAG-HA-tagged TRIM71 (TRIM71), FLAG-HA-tagged TRIM71 deletion mutants (NHL, RING/B1, TRIM)
or empty control vector (ctrl). Western blots were probed with antibodies against the indicated endogenous proteins or HA.
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consensus (26). To address this, we analysed individual
TRIM71 targets. CCNE2, which shows the strongest
repression by TRIM71 among genes tested, is associated
with PUM1 and PUM2 in HeLa (26) and with
PUM2 in HEK293 cells (29), and contains two PUM
motifs. Indeed, knock-down of either PUM protein
alone (Supplementary Figure S6) or in combination
(Figure 5b) relieved repression of the CCNE2 reporter.
Thus, CCNE2 is repressed by PUM1/2 in HEK293
cells. However, knock-down of PUM proteins had no
effect on TRIM71-mediated repression (Figure 6b and
Supplementary Figure S6).
We analysed two further TRIM71 targets, E2F7 and
STAT5B. Although E2F7 has no PUM motif, it is
associated with PUM2 in HEK293 cells (29) and, consist-
ently, showed appreciable relief of repression when
PUM proteins were knocked-down (Figure 6b and
Supplementary Figure S6). STAT5B is considered not to
be a PUM target (26,29) and, as expected, showed no re-
pression relief upon PUM1/2 knock-down. Importantly,
for E2F7 and STAT5B, knock-down of PUM1/2 did not
affect TRIM71-mediated repression of the reporters
(Figure 6b and Supplementary Figure S6).
Thus, PUM proteins are dispensable for TRIM71-
mediated repression and most likely do not mediate
TRIM71 association with RNA.
TRIM71 and the miRNA pathway repress
common targets
TRIM-NHL proteins have been shown to directly or
indirectly interact with AGO proteins, either positively
or negatively affecting miRNA-mediated repression in
various organisms (6–9). The molecular details of
TRIM-NHL enhancement of miRNA-mediated repres-
sion and the factors determining positive or negative regu-
lation are not well-understood.
We detected a robust interaction between TRIM71 and
AGO2 that was mediated by the NHL domain (Figure 4e
and Supplementary Figure S3). Since this interaction
was weakened but not completely abolished by RNase
A treatment (with 10–40% remaining; n=4), we
examined the possibility that association of TRIM71
with RNA is mediated by AGO proteins. Mammals
express four different AGOs (AGO1–4) that participate
in miRNA-mediated repression and TRIM71 interacts
with all tested AGOs (8). To investigate the potential in-
volvement of AGO proteins in TRIM71-mediated repres-
sion, we knocked-down AGO1 and AGO2, the most
abundant AGO proteins in HEK293 cells (30), monitoring
knock-down efﬁciency using the established let-7 miRNA
reporter HMGA2 (22). As expected, simultaneous AGO1/
2 knock-down partially relieved HMGA2 repression
(Figure 7a). Likewise, knock-down of AGO1/2 caused sig-
niﬁcant relief of the CCNE2, HOXA5, STAT5B, MYB
and ZNF362 30UTR reporters (Figure 7b), indicating
that these mRNAs are under the control of miRNAs in
HEK293 cells. Indeed CCNE2, HOXA5 and MYB were
identiﬁed previously as miRNA targets by AGO/TNRC6
immunoprecipitation in HEK293 cells (31). In marked
contrast, AGO1/2 knock-down did not relieve
TRIM71-mediated repression of the CCNE2, HOXA5,
STAT5B, E2F7, MYB and ZNF362 reporters
(Figure 7b). Thus, repression by TRIM71 appears to be
independent of AGO proteins.
To further investigate the potential co-regulation of
TRIM71 targets by miRNAs, we turned to the E2F7
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Figure 6. Repression by TRIM71 is independent of mammalian PUM1 and PUM2. (a) The PUM consensus motif is not enriched in 30UTRs of
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HEK293 cells were co-transfected with indicated FL-30UTR reporters, plasmids expressing TRIM71 or LacZ and a combination of siRNAs
against PUM1 and PUM2, or a non-targeting control siRNA as indicated. FL was normalized to RL and values of normalized FL produced
from samples expressing LacZ and the non-targeting control siRNA were set to 1. *P-value< 0.05; **P-value< 0.01.
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30UTR reporter, which was identiﬁed by us as a TRIM71
target. E2F7 showed no repression relief upon AGO1/2
knock-down in HEK293 cells (Figure 7c), suggesting that
it is not repressed bymiRNAs in these cells. However,E2F7
was identiﬁed as a target of miR-302 (17), an ES-cell-
speciﬁc miRNA. Indeed, expression of miR-302 mimic in
HEK293 cells led to repression of the E2F7 reporter as
compared to an unrelated siRNA used as a control mimic
(Figure 7c). Additional expression of TRIM71 resulted in
stronger repression than that seen in the presence of
miR-302 alone. Thus, both TRIM71 and miR-302 repress
the E2F7 mRNA, probably independently.
Taken together, the data suggest that some TRIM71-
targeted mRNAs are also under the control of the miRNA
pathway but that inhibition by the two classes of repres-
sors is independent. This conclusion is consistent with our
observation that, despite the interaction between AGO2
and TRIM71 being relatively robust, AGO2 is not found
enriched in TRIM71 IPs (Figure 1), indicating that only a
minor fraction of AGO2 is associated with TRIM71.
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Figure 7. TRIM71 and miRNAs pathway repress common targets. (a) Knock-down of AGO1 and AGO2 partially relieves miRNA-mediated
repression. To monitor AGO knock-down efﬁciency, HEK293 cells were co-transfected with FL reporter constructs containing the 30UTR of the
let-7 target HMGA2 either (wt) or with its let-7 binding sites mutated (mut), a plasmid expressing pri-let-7 and siRNAs against AGO1 and AGO2
(either individually or in combination), or a non-targeting control siRNA as indicated. Values of normalized FL produced from reporters containing
the mutated 30UTR were set to 1. (b) TRIM71-mediated repression is independent of AGO proteins. HEK293 cell were co-transfected with indicated
FL-30UTR reporter constructs, plasmids expressing either TRIM71 or LacZ, and either a combination of siRNAs against AGO1 and AGO2
(siAGO1/2) or a non-targeting control siRNA (ctrl siRNA) as indicated. FL was normalized to RL and values of normalized FL produced in
the presence of LacZ and the non-targeting control siRNA were set to 1. (c) Co-repression of the E2F7 FL-30UTR reporter by TRIM71 and
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indicated TRIM71-TRIM32 chimeras, or with plasmids expressing LacZ (not shown). FL was normalized to RL and values of normalized FL
produced in the presence of LacZ were set to 1. (bottom) Protein expression was estimated by western blotting with antibodies against HA.
*P-value< 0.05; **P-value< 0.01.
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TRIM71 and TRIM32 act via a similar molecular
mechanism
Our results suggested that full repression of some mRNAs
requires activity of both TRIM71 andmiRNAs, a situation
that could be perceived as enhancement of miRNA-
mediated repression by TRIM71. A similar effect (an
enhancement of miRNA-mediated repression with no
effect on miRNA levels) has been described for the mam-
malian TRIM71 paralog TRIM32 and the C. elegans
TRIM-NHL protein NHL-2 (6,9). We hypothesized that
the molecular mechanisms of action of TRIM32 and
TRIM71 are similar. Indeed tethering of TRIM32 (but
not TRIM2 or TRIM3) also led to reporter repression,
albeit to a lesser extent than for TRIM71 (Supplementary
Figure S7b). However, expression of TRIM32 did not or
only weakly repressed the TRIM71 target genes CCNE2,
HOXA5, STAT5B or E2F7 (Figure 7d), indicating that
the target repertoires of TRIM71 and TRIM32 differ.
Given that the NHL domain was found to be necessary
and sufﬁcient to target TRIM71 to RNA, we performed
a domain-swap experiment, replacing the NHL domain of
TRIM71 with that of TRIM32 and vice versa. A chimera
of TRIM32 with the NHL domain of TRIM71 (TRIM32/
NHL71) repressed the TRIM71 targets, whereas
TRIM71/NHL32 did not (Figure 7d), arguing that both
TRIM32 and TRIM71 have the potential to repress
mRNAs and that target speciﬁcity is provided by the
NHL domain.
In contrast to TRIM32, which enhances miRNA repres-
sion (9), TRIM71 was described previously as a negative
regulator of miRNA-mediated repression, facilitating
ubiquitination of AGO2 and targeting it for proteasomal
degradation (8). Although we also observed ubiquitination
of AGO2, facilitated by either TRIM71 or TRIM32
(Supplementary Figure S8a and b), neither TRIM71 nor
TRIM32 affected AGO2 stability (Supplementary Results,
Figure 3c, Supplementary Figure S8c and d). This argues
against a general negative effect of TRIM71 or TRIM32 on
AGO-mediated repression.
In conclusion, our data support a model of TRIM71 as
a repressor of mRNA function that shares targets with
miRNAs, but with the two classes of repressors function-
ing independently.
DISCUSSION
TRIM71 as a repressor of mRNAs
Our results identify the mammalian TRIM-NHL protein
TRIM71 as a repressor of mRNA function. TRIM71 as-
sociates with mRNAs, resulting in translational repression
and mRNA degradation. We have identiﬁed several
TRIM71 targets and shown that TRIM71 acts via their
30UTR. This novel role of TRIM71 as a repressor of
mRNA function is reminiscent of the documented role
of the Drosophila TRIM-NHL protein BRAT, which
inhibits translation of several mRNAs in the early
embryo (5), the female germline (32), and the nervous
system (4). Strikingly, the similarities between TRIM71
and BRAT extend to the fact that mutations of individual
conserved residues within the NHL domain, known to
abrogate BRAT function (27), also abolish the ability of
TRIM71 to repress its targets.
The role of TRIM71 as a repressor of mRNAs is
consistent with the proposed role of LIN-41, the
C. elegans TRIM71 ortholog, to negatively and post-
transcriptionally regulate expression of the Zn-ﬁnger
transcription factor lin-29 (10). Very recently, the
Drosophila TRIM-NHL protein Mei-P26 was shown to
repress mRNAs in ovarian germline stem cells (33).
Given the structural similarities of TRIM-NHL proteins
(2), it is conceivable that other family members also
repress mRNAs. Our results indicate that at least mam-
malian TRIM32 has the potential to do so when tethered
to RNA. The activity of TRIM-NHL proteins in repress-
ing mRNAs is further supported by the observation
that several TRIM-NHL proteins, including mammalian
TRIM32 and TRIM71, Drosophila BRAT, Mei-P26
and Dappled, and C. elegans NHL-2, interact directly or
indirectly with AGO proteins and other miRNA pathway
components (6–9,33).
Physiological role of TRIM71
LIN-41 prevents premature differentiation of epidermal
stem cells by negatively regulating the differentiation-
promoting transcription factor lin-29 in C. elegans (10).
The high expression of mammalian TRIM71 in undiffer-
entiated cells (8), its negative regulation by let-7 (8,15,18),
and its indirect up-regulation by ES-cell-speciﬁc miRNAs
(17) suggest that the activity of TRIM71/LIN-41 to
maintain an undifferentiated state is conserved; and
indeed recently, mouse TRIM71 was shown to promote
self-renewal and proliferation of embryonic neuronal pro-
genitor cells and to prevent their premature differentiation
(34). Consistent with this role, we have identiﬁed Rbl1 and
Rbl2 as TRIM71 targets in mES cells. RBL1 and RBL2
are transcription factors that negatively regulate the
expression of cell cycle-dependent genes and their down-
regulation by the action of ES-cell-speciﬁc miRNAs was
shown previously to be important for stem cell mainten-
ance and differentiation (19,35,36).
We also detected moderate repression of Ccnd2 by
TRIM71 in both HEK293 and mES cells. Although an
involvement of CCND2 down-regulation in mES cell
regulation has not been reported, CCND2 was shown pre-
viously to be targeted by an ES-cell-speciﬁc miRNA in
human ES cells (37). Furthermore, Ccnd2 mRNA levels
are strongly up-regulated upon neuronal differentiation of
mES cells (J. Krol and W.F., unpublished results). Thus,
keeping CCND2 levels low might contribute to stem cell
maintenance or inhibition of premature differentiation.
It remains to be determined whether the TRIM71
targets identiﬁed in HEK293 cells, particularly CCNE2,
are physiologically relevant. Interestingly, 15% of tran-
scripts down-regulated by TRIM71 in HEK293 cells are
Zn-ﬁnger transcription factors (compared with 2% of
up-regulated genes; Supplementary Table S2). These
include Znf362, the closest mammalian homolog of
Lin-29, which represents the only proposed target of
LIN-41. Znf362 mRNA was also enriched in TRIM71
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IPs and its 30UTR was repressed 1.5-fold by TRIM71,
suggesting that some TRIM71/LIN-41 targets are evolu-
tionary conserved.
Notably, although TRIM71 and BRAT (and possibly
other TRIM-NHL proteins) appear very similar at the
molecular level, their target repertoires and thus their
physiological activities differ. TRIM71 and LIN-41 are
highly expressed in undifferentiated cells and repress
targets like Rbl1/2 and possibly lin-29, respectively,
thereby maintaining the undifferentiated state. The
opposite is true for BRAT, which is absent in undifferen-
tiated cells and up-regulated upon differentiation
(32,38,39). Of the other TRIM-NHL proteins, TRIM32
and NHL-2 have also been shown to drive differentiation
(6,9,40), while Mei-P26 was reported to either prevent (33)
or promote differentiation (7), depending on the cellular
context. Thus, knowing what determines the speciﬁcity of
TRIM-NHL proteins for mRNA targets will be important
for understanding their physiological roles.
The NHL domain
Wehave identiﬁed theNHL domain, the deﬁning feature of
TRIM-NHL proteins, as necessary and sufﬁcient to target
TRIM71 to RNA. Domain-swap experiments between
TRIM71 and TRIM32 indicated that the NHL domain
provides speciﬁcity to target repression. Interestingly,
ﬁve out of seven alleles identiﬁed in the initial screen
recognizing lin-41 as a heterochronic gene have single
amino acid substitutions within the NHL domain,
emphasizing its importance for protein activity (10). Also
in the case of BRAT,most mutations abrogating its activity
have been mapped to NHL (5,27,28).
Interestingly, mutation of the NHL residues conserved
between TRIM71 and BRAT that are important for
BRAT– PUM interaction and BRAT activity also abol-
ished the ability of TRIM71 to repress its targets.
Moreover, NHL of TRIM71 was found to interact in an
RNA-dependent manner with the two mammalian PUM
homologs PUM1 and PUM2. Despite these apparent
similarities, two lines of evidence make it unlikely that
mammalian PUM1/2 mediate association of TRIM71
with RNA: the PUM consensus motif is not enriched in
the 30-UTRs of identiﬁed TRIM71 targets, and simultan-
eous knock-down of both PUM1/2 does not abolish
TRIM71-mediated repression. Therefore, we favor the
possibility that the TRIM71 and PUM1/2 interaction is
mediated by RNA and that TRIM71 and PUM1/2 share
many mRNA targets. In support of this hypothesis, some
TRIM71 targets we identiﬁed (CCNE2, HOXA5, E2F7,
MYB and CCND2) have been found associated with
PUM2 in HEK293 cells (29). Consistently, repression of
several tested TRIM71 targets was partially relieved upon
PUM1/2 knock-down in the absence of TRIM71 in
HEK293 cells.
It is conceivable that TRIM71 interacts directly with
RNA. The NHL domain forms a ß-propeller structure
that resembles structures of WD-40 domains (27). Lau
et al. found that the WD-40 domain of Gemin5 contacts
RNA directly (41) and more recently the WD-40 motif has
also been identiﬁed as putative new RNA-binding
platform by Castello et al. (42). Hence, it is possible that
the NHL domain mediates association of TRIM-NHL
proteins with mRNAs by directly contacting RNA.
Interestingly, all identiﬁed mutations that abrogate
BRAT (27), TRIM71 (our work) and Lin-41 (10)
activity lie at the electropositive ‘top’ surface of the
NHL ß-propeller structure. We attempted to identify the
RNA motif that is responsible for TRIM71 association
with mRNA. However, neither the dissection of the
30UTR of the TRIM71 target CCNE2 nor a bioinformatic
motif enrichment analysis of TRIM71-associated mRNAs
revealed a candidate sequence motif (data not shown),
possibly indicating that association of TRIM71 involves
some structural RNA features.
TRIM71 and miRNA-mediated repression
Individual mRNAs are regulated by the interplay of a
multitude of different RBPs and miRNAs that control
mRNA function. Moreover, single RBPs or miRNAs
can target hundreds of mRNAs, forming complex regula-
tory networks that ﬁne-tune gene expression (43). Not
surprisingly, we found that many TRIM71 targets are
also subject to miRNA repression: their expression
increased upon knock-down of AGO1/2 in HEK293
cells. Furthermore, many of them have been shown previ-
ously to be associated with AGO proteins (29,31),
indicating that TRIM71 and the miRNA pathway share
common targets. Consistent with this, the TRIM71 targets
we identiﬁed in mES cells are either predicted (Rbl1) or
conﬁrmed (Rbl2 and CCND2) targets of ES-cell-speciﬁc
miRNAs (19,36,37). As exempliﬁed by E2F7, full repres-
sion of these targets requires expression of both miRNA
and TRIM71.
Our model that full repression of some miRNA targets
requires expression of TRIM71 resembles observations
made for mouse TRIM32 and C. elegans NHL-2, which
were shown to enhance miRNA-mediated repression
by an as yet unknown mechanism without affecting
miRNA levels (6,9). While these reports suggested a role
for TRIM-NHL proteins as co-factors or modulators of
miRNPs (6), our results indicate that TRIM71 (and
possibly other TRIM-NHL proteins) repress mRNAs in-
dependent of the miRNA pathway. Consistent with
TRIM-NHL proteins being independent repressors
sharing some targets with miRNAs is a recent report iden-
tifying Mei-P26 as a repressor of brat and orb mRNAs
(33). While repression of orb required both AGO1 and
Mei-P26, repression of brat by Mei-P26 was miRNA-
independent. A common mechanism for TRIM-NHL
proteins is also inferred from observations that the
NHL domain, which is necessary for TRIM71 and
BRAT association with RNA, is likewise required for
TRIM32 enhancement of miRNA-mediated repression,
but the RING/E3-ligase domain, which is dispensable
for TRIM71 function (and absent in BRAT), is also dis-
pensable for the enhancement of miRNA-mediated re-
pression by TRIM32 (9).
In contrast to the examples of TRIM-NHL proteins au-
gmenting the effects of miRNAs, there are also reports
of Mei-P26 and TRIM71 as negative miRNA-pathway
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regulators (7,8). Notably, TRIM71 was shown to
ubiquitinate AGO2, targeting it for proteasomal degrad-
ation and thereby antagonizing miRNA function (8). This
effect is not consistent with the repressive activity of
TRIM-NHL proteins identiﬁed by us and others
(6,9,32,33) and accordingly a more recent report found
no evidence for an effect of TRIM71 on AGO2 stability
or ubiquitination (34). Although we found that both
TRIM71 and TRIM32 can facilitate AGO2 ubiquitina-
tion, we also did not detect negative effects of TRIM71
or TRIM32 expression on AGO2 stability, either en-
dogenous or when overexpressed. We mapped several
ubiquitination sites in AGO2 but have been unable so
far to identify their signiﬁcance (unpublished results).
Ubiquitination of endogenous AGO proteins by a global
approach has also been reported recently (44). AGO
protein ubiquitination is certainly not required for the
activity of TRIM71 as a repressor of mRNAs, given
that its RING domain, and thus ubiquitin ligase
activity, is dispensable for TRIM71-mediated repression.
This property is shared with BRAT, an incomplete TRIM
protein lacking the RING domain.
When our article was ready for submission, Chang et al.
(45) reported that Cdkn1a mRNA is co-repressed by
TRIM71 and miR-302 in mES cells. Similar to our
results, they also found that TRIM71 does not cause de-
stabilization of AGO2.
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